Clinical Research at MENA
Peter Lang Gmbh, Internationaler Verlag Der Wissenschaften
978-3-631-81113-9 (ISBN)
The meaning of Clinical Trials for humans has recently changed significantly,
"evolved", so to speak. In today's environment, where ethical validity is much more
strictly controlled, this meaning is far beyond "human drug testing" and much closer
to the "therapeutic goal". The number of clinical trials in western countries that have
perceived this change has increased rapidly and continues to increase. Although
the number of clinical studies in the MENA region is increasing day by day, it is still
far from its potential. Among the reasons for this are legal, technological, ethical,
epidemiological, educational and economic factors. This book presents both the
difficulties encountered in conducting clinical trials in MENA and suggestions for
solving these difficulties.
lt;p>Fatih graduated as a Medical Doctor from Hacettepe School of Medicine in 1990 and practiced clinical medicine in Turkey for 5 years. He obtained PhD in Pharmacology from Temple University in USA in 2000 and worked as a postdoctoral researcher at the same university prior to joining academia.
Fatih has broad pharmaceutical industry experience at different local and regional medical functions including clinical operations, clinical quality and medical management in Turkey, Middle East and Africa. He has more than twenty publications in the fields of molecular and clinical pharmacology.
Currently, he is a faculty member and a member of management board at Bahcesehir University School of Medicine and the program coordinator of Pharmaceutical Medicine master's degree program at the same university.
lt;i>
Fatih Özdener : General Picture of Clinical Research at MENA - Hamdi Akan : Clinical Trial Designs of the Future - Getting Ready at MENA - Nihan Burul Bozkurt, Gökhan Özkan : The Role of Regulatory Authorities and TITCK - Irfan Çiçin, Ali Gökyer : Role of Investigator - Peri Aytaç, Aydin Erenmemisoglu : Early Phase Clinical Trials - Importance of Entry to MENA - Özgür Kasapçopur, Mehmet Yildiz, Fatih Özdener : Ethical Considerations (Clinical Research in Pediatric and Sensitive Populations) - Bilge Aydin Temiz : The Requirement and Importance of Legal Regulations in Drug Clinical Trials - Mutlu Hayran, Deniz Yüce : Importance of Epidemiological Data - Baris Erdogan, Le Vin Chin : Clinical Research and Healthcare Digitalization in the Middle East and Turkey - Fatih Ozdener : Sponsoring Clinical Trials at MENA - Need for New Pharmacoeconomic Models - Fatih Özdener, Alihan Sürsal, Zülfiye Gül : Good Clinical Practice Training from the Perspective of Raising Clinical Trial Awareness .
| Erscheinungsdatum | 14.10.2021 |
|---|---|
| Verlagsort | Frankfurt a.M. |
| Sprache | englisch |
| Maße | 148 x 210 mm |
| Gewicht | 262 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie |
| Wirtschaft ► Volkswirtschaftslehre | |
| Schlagworte | challenges • Clinical • Clinical Research and Healthcare Digitalization in the Middle East and Turkey • Clinical Trial Designs of the future-Getting ready at MENA • Early phase CTs-Importance of entry to MENA • ethical considerations • Fatih • General Picture of Clinical Research at MENA • Importance of Epidemiological Data • Improving awareness through training for CTs • MENA • Özdener • Role of Investigator • Role of Regulatory Authority • Solutions • Sponsoring CTs at MENA-Need of new pharmacoeconomic models • Sponsoring CTs at MENA-Need of new pharmacoeconomic models • The Requirement and Importance of Legal Regulations in Drug Clinical Trials |
| ISBN-10 | 3-631-81113-6 / 3631811136 |
| ISBN-13 | 978-3-631-81113-9 / 9783631811139 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
